Advanced Search

2022 Vol. 4, No. 10

Commentary
Strengthening Community Defenses to Prevent and Control the Spread of COVID-19 in China
Xia Li, Zhuona Zhang, Keyang Lyu, Dongqun Xu
2022, 4(10): 191-194. doi: 10.46234/ccdcw2022.030
Abstract(9542) HTML (364) PDF 92KB(55)
Abstract:

In light of the severity of coronavirus disease (COVID-19) around the world, it is an arduous task for China to prevent COVID-19 from being imported from abroad and proliferating domestically. The community is the first and most effective line of defense and can effectively cut off the channels of spread of the epidemic. In order to reduce risks of COVID-19 transmission in the community, it is necessary to sort out the loopholes in risk and management, as well as investigate previous epidemic transmission events in the community.

Preplanned Studies
Diagnostic Value of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Severe COVID-19 — 7 PLADs, China, January 21–February 10, 2020
Yan Ma, Dongshan Zhu, Nannan Shi, Lei Zhang, Guangkun Chen, Youwen Ge, Zelei Zhang, Renbo Chen, Sihong Liu, Yipin Fan, Huamin Zhang, Yanping Wang
2022, 4(10): 195-198. doi: 10.46234/ccdcw2022.047
Abstract(5226) HTML (408) PDF 303KB(19)
Abstract:
What is already known about this topic?

Coronavirus disease 2019 (COVID-19) causes symptoms ranging from mild to severe. Indicators for identifying severe COVID-19 infection have not been well identified, especially for young patients.

What is added by this report?

Both neutrophil-lymphocyte ratio (NLR) [area under curve (AUC): 0.80; the odds ratios (OR)and 95% confidence intervals ( 95% CI): 1.30 (1.13–1.50)] and platelet-lymphocyte ratio (PLR) [AUC: 0.87; OR (95% CI): 1.05 (1.01–1.09)] were determined to be indicators for recognition of patients with severe COVID-19 in young patients less than age 40.

What are the implications for public health practice?

NLR and PLR are useful indicators for identifying patients with severe COVID-19, especially in young patients less than age 40.

Methods and Applications
When and How to Adjust Non-Pharmacological Interventions Concurrent with Booster Vaccinations Against COVID-19 — Guangdong, China, 2022
Guanhao He, Fangfang Zeng, Jianpeng Xiao, Jianguo Zhao, Tao Liu, Jianxiong Hu, Sicong Zhang, Ziqiang Lin, Huaiping Zhu, Dan Liu, Min Kang, Haojie Zhong, Yan Li, Limei Sun, Yuwei Yang, Zhixing Li, Zuhua Rong, Weilin Zeng, Xing Li, Zhihua Zhu, Xiaofeng Liang, Wenjun Ma
2022, 4(10): 199-206. doi: 10.46234/ccdcw2022.048
Abstract(9457) HTML (287) PDF 1197KB(46)
Abstract:
Introduction

With the large-scale roll-out of the coronavirus disease 2019 (COVID-19) booster vaccination effort (a vaccine dose given 6 months after completing primary vaccination) in China, we explore when and how China could lift non-pharmacological interventions (NPIs) against COVID-19 in 2022.

Methods

Using a modified susceptible-infectious-recovered (SIR) mathematical model, we projected the COVID-19 epidemic situation and required medical resources in Guangdong Province, China.

Results

If the number of people entering from overseas recovers to 20% of the number in 2019, the epidemic in 2022 could be controlled at a low level by a containment (215 local cases) or suppression strategy (1,397 local cases). A mitigation strategy would lead to 21,722 local cases. A coexistence strategy would lead to a large epidemic with 6,850,083 local cases that would overwhelm Guangdong’s medical system. With 50% or 100% recovery of the 2019 level of travelers from overseas, the epidemic could also be controlled with containment or suppression, but enormous resources, including more hotel rooms for border quarantine, will be required. However, coexistence would lead to an uncontrollable epidemic with 12,922,032 local cases.

Discussion

With booster vaccinations, the number of travelers from overseas could increase slightly in 2022, but a suppression strategy would need to be maintained to ensure a controllable epidemic.

Outbreak Reports
A Limited Spreading Event of COVID-19 Caused by Delta Variant in a Cosmetic Hospital — Yantai City, Shandong Province, China, 2021
Yang Han, Wenkui Sun, Shengyang Zhang, Bin Lin, Jingyu Liu, Runze Lu, Xiaolin Jiang, Jie Lei
2022, 4(10): 207-210. doi: 10.46234/ccdcw2022.033
Abstract(6194) HTML (332) PDF 286KB(40)
Abstract:
What is already known about this topic?

Coronavirus disease 2019 (COVID-19) outbreaks in the past were mostly caused by overseas transmission, but if control measures are not appropriately applied, domestic transmission could also cause large-scale local epidemics.

What is added by this report?

This report covers all information of epidemic investigation processes, epidemiological characteristics and exposure history, transmission chains, sequencing results as well as public health measures taken for the COVID-19 cluster epidemic caused by the Delta variant in a cosmetic hospital in Yantai City in August 2021.

What are the implications for public health practice?

The information provided in this report, including active case finding, community management, and mass testing, may assist public health professionals in dealing with local COVID-19 epidemics caused by domestic transmission.